JP2007525521A5 - - Google Patents

Download PDF

Info

Publication number
JP2007525521A5
JP2007525521A5 JP2007501006A JP2007501006A JP2007525521A5 JP 2007525521 A5 JP2007525521 A5 JP 2007525521A5 JP 2007501006 A JP2007501006 A JP 2007501006A JP 2007501006 A JP2007501006 A JP 2007501006A JP 2007525521 A5 JP2007525521 A5 JP 2007525521A5
Authority
JP
Japan
Prior art keywords
compound
group
alkyl
hcv
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007501006A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007525521A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/006083 external-priority patent/WO2005085197A1/en
Publication of JP2007525521A publication Critical patent/JP2007525521A/ja
Publication of JP2007525521A5 publication Critical patent/JP2007525521A5/ja
Pending legal-status Critical Current

Links

JP2007501006A 2004-02-27 2005-02-24 Ｃ型肝炎ウイルスｎｓ３セリンプロテアーゼのインヒビターとしてのシクロブテンジオン基含有化合物 Pending JP2007525521A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54842304P 2004-02-27 2004-02-27
PCT/US2005/006083 WO2005085197A1 (en) 2004-02-27 2005-02-24 Cyclobutenedione groups-containing compounds as inhibitors of hepatitis c virus ns3 serine protease

Publications (2)

Publication Number Publication Date
JP2007525521A JP2007525521A (ja) 2007-09-06
JP2007525521A5 true JP2007525521A5 (https=) 2008-03-21

Family

ID=34919362

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007501006A Pending JP2007525521A (ja) 2004-02-27 2005-02-24 Ｃ型肝炎ウイルスｎｓ３セリンプロテアーゼのインヒビターとしてのシクロブテンジオン基含有化合物

Country Status (5)

Country Link
EP (1) EP1742914A1 (https=)
JP (1) JP2007525521A (https=)
CN (1) CN1946690A (https=)
CA (1) CA2557301A1 (https=)
WO (1) WO2005085197A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060281689A1 (en) * 2005-06-02 2006-12-14 Schering Corporation Method for modulating activity of HCV protease through use of a novel HCV protease inhibitor to reduce duration of treatment period
US20060276404A1 (en) * 2005-06-02 2006-12-07 Anima Ghosal Medicaments and methods combining a HCV protease inhibitor and an AKR competitor
US20070021351A1 (en) * 2005-06-02 2007-01-25 Schering Corporation Liver/plasma concentration ratio for dosing hepatitis C virus protease inhibitor
AU2006252623A1 (en) * 2005-06-02 2006-12-07 Schering Corporation Controlled-release formulation useful for treating disorders associated with hepatitis C virus
US20060276407A1 (en) * 2005-06-02 2006-12-07 Schering Corporation Methods of treating hepatitis C virus
WO2006130552A2 (en) * 2005-06-02 2006-12-07 Schering Corporation Methods of treating hepatitis c virus
US20060275366A1 (en) * 2005-06-02 2006-12-07 Schering Corporation Controlled-release formulation
UA96283C2 (uk) 2005-12-23 2011-10-25 Зіланд Фарма А/С Модифіковані міметики лізину
US7816348B2 (en) 2006-02-03 2010-10-19 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
JP2010500978A (ja) 2006-08-17 2010-01-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ウイルスポリメラーゼインヒビター
EP2074087A2 (en) 2006-12-21 2009-07-01 Wyeth Synthesis of pyrrolidine compounds
CA2693997C (en) 2007-08-03 2013-01-15 Pierre L. Beaulieu Viral polymerase inhibitors
CN101903351B (zh) 2007-12-19 2014-09-10 贝林格尔.英格海姆国际有限公司 病毒聚合酶抑制剂
JP2012514605A (ja) 2009-01-07 2012-06-28 サイネクシス，インコーポレーテッド Ｈｃｖおよびｈｉｖ感染の治療への使用におけるシクロスポリン誘導体
CN103387510B (zh) * 2013-08-08 2015-09-09 苏州永健生物医药有限公司 一种β-氨基-alpha-羟基环丁基丁酰胺盐酸盐的合成方法
CN110709096B (zh) 2017-05-05 2023-10-31 泽兰德制药公司 细胞间隙连接通讯调节剂及其在糖尿病性眼病治疗中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5168103A (en) * 1991-01-22 1992-12-01 American Home Products Corporation [[2-(amino-3,4-dioxo-1-cyclobuten-1-yl) amino]alkyl]-acid derivatives
US6323180B1 (en) * 1998-08-10 2001-11-27 Boehringer Ingelheim (Canada) Ltd Hepatitis C inhibitor tri-peptides
UA74546C2 (en) * 1999-04-06 2006-01-16 Boehringer Ingelheim Ca Ltd Macrocyclic peptides having activity relative to hepatitis c virus, a pharmaceutical composition and use of the pharmaceutical composition
ES2240446T3 (es) * 2000-04-03 2005-10-16 Vertex Pharma Inhibidores de serina proteasas, particularmente la proteasa ns3 del virus de la hepatitis c.
DK1385870T3 (da) * 2000-07-21 2010-07-05 Schering Corp Peptider som inhibitorer af NS3-serinprotease fra hepatitis C-virus
US7244721B2 (en) * 2000-07-21 2007-07-17 Schering Corporation Peptides as NS3-serine protease inhibitors of hepatitis C virus
KR20030081297A (ko) * 2000-07-21 2003-10-17 쉐링 코포레이션 Ｃ형 간염 바이러스의 ｎｓ3-세린 프로테아제억제제로서의 신규한 펩티드
WO2002062761A1 (en) * 2001-02-07 2002-08-15 Abbott Laboratories Aminal diones as potassium channel openers
US20040106794A1 (en) * 2001-04-16 2004-06-03 Schering Corporation 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
CN1289471C (zh) * 2001-04-16 2006-12-13 先灵公司 作为cxc－趋化因子受体配体的3,4－二取代的环丁烯－1,2－二酮

Similar Documents

Publication Publication Date Title
JP2007525510A5 (https=)
JP2007525514A5 (https=)
JP2007535496A5 (https=)
JP2007525512A5 (https=)
JP2007525518A5 (https=)
JP2008511633A5 (https=)
JP2004504404A5 (https=)
JP2005524628A5 (https=)
JP2007525521A5 (https=)
RU2006124594A (ru) Ингибиторы сериновой протеазы ns3/ns4а вируса гепатита с
JP2005515255A5 (https=)
JP2004513881A5 (https=)
JP2007535491A5 (https=)
RU2006134002A (ru) Новые соединения, действующие как ингибиторы сериновой протеазы ns3 вируса гепатита с
RU2006134005A (ru) Новые соединения, действующие как ингибиторы сериновой протеазы ns3 вируса гепатита с
JP2007515405A5 (https=)
RU2006134003A (ru) Серосодержащие соединения, действующие как ингибиторы сериновой протеазы ns3 вируса гепатита с
RU2006134000A (ru) Новые кетоамиды с циклическим p4s, действующие как ингибиторы сериновой протеазы ns3 ируса гепатита с
JP2007513971A5 (https=)
EP2368900A3 (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
WO2004113365A3 (en) Hepatitis c serine protease tri-peptide inhibitors
JP2007532479A5 (https=)
JP2007534636A5 (https=)
CA2410662A1 (en) Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
RU2004125279A (ru) Новые пептиды, как ингибиторы ns3-серинпротеазы вируса гепатита c